| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.03B | +27.2% |
| Cost of Revenue | $4.98B | +22.4% |
| R&D Expense | $50.4M | -5.4% |
| SG&A Expense | $279.2M | -0.3% |
| Operating Income | -$281.2M | +38.8% |
| Interest Expense | $244.1M | +0.6% |
| Pre-tax Income | -$539.4M | +2.8% |
| Income Tax | $5.2M | +130.2% |
| Net Income | -$545.7M | -0.9% |
| EPS (Basic) | -$5.21 | -0.4% |
| EPS (Diluted) | -$5.21 | -0.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $658.6M | -55.5% |
| Accounts Receivable | $489.5M | +6.0% |
| Inventory | $1.47B | +6.4% |
| Current Assets | $3.16B | -17.0% |
| Total Assets | $6.67B | -13.8% |
| Current Liabilities | $1.95B | +4.1% |
| Long-term Debt | $3.67B | +2.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$394.6M | -524.4% |
| Capital Expenditures | $121.6M | -19.3% |
| Investing Cash Flow | -$155.5M | +5.1% |
| Financing Cash Flow | -$261.0M | -59.6% |
| Free Cash Flow | -$516.2M | -141.4% |
| Stockholders' Equity |
| -$247.5M |
| -155.2% |